Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 3.8B | 3.6B | 3.1B | 3.9B |
Cost of revenue | 2.3B | 2.1B | 1.7B | 1.6B |
Gross profit | 1.5B | 1.5B | 1.4B | 2.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | -711M |
Other operating expenses | -45M | 260M | 12M | 194M |
Operating income | 663M | 94M | 931M | 182M |
Non operating interest income | ||||
Income | -632M | 72M | 388M | 299M |
Expense | -497M | 351M | 698M | 801M |
Other income expense | — | — | — | — |
Pretax income | 34M | 53M | 470M | -300M |
Tax provision | 74M | 67M | -9M | 42M |
Net income | -42M | 181M | -161M | -342M |
Basic EPS | — | — | — | 0.0 |
Diluted EPS | — | — | — | 0.0 |
Basic average shares | — | — | — | 21.3B |
Diluted average shares | — | — | — | 21.3B |
EBITDA | 525M | 1.1B | 1.7B | 1.7B |
Net income from continuing op. | -40M | -14M | 479M | -342M |
Minority interests | -59M | -44M | -85M | -58M |
Preferred stock dividends | 0 | 0 | 0 | 0 |